CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 132 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $145 | -79.7% | 4,556 | -84.5% | 0.00% | -87.5% |
| Q1 2023 | $716 | +56.7% | 29,354 | +102.4% | 0.01% | +33.3% |
| Q4 2022 | $457 | -99.8% | 14,505 | +41.7% | 0.01% | +50.0% |
| Q3 2022 | $289,000 | -44.4% | 10,234 | -48.0% | 0.00% | -33.3% |
| Q2 2022 | $520,000 | +102.3% | 19,671 | +148.6% | 0.01% | +500.0% |
| Q4 2021 | $257,000 | -65.3% | 7,913 | -68.4% | 0.00% | -66.7% |
| Q3 2021 | $740,000 | -64.7% | 25,068 | -69.3% | 0.00% | -70.0% |
| Q2 2021 | $2,094,000 | – | 81,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,965,701,000 | 23.51% |
| Affinity Asset Advisors, LLC | 225,000 | $7,295,000 | 2.65% |
| Perceptive Advisors | 10,173,454 | $329,822,000 | 2.54% |
| Artal Group S.A. | 1,500,000 | $48,630,000 | 1.32% |
| Rock Springs Capital Management LP | 1,648,435 | $53,442,000 | 1.24% |
| RTW INVESTMENTS, LP | 666,666 | $21,613,000 | 0.32% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 8,900 | $289,000 | 0.28% |
| EAM Investors, LLC | 39,907 | $1,294,000 | 0.21% |
| FEDERATED HERMES, INC. | 3,113,333 | $100,934,000 | 0.19% |
| Alkeon Capital Management | 1,909,035 | $61,891,000 | 0.12% |